Literature DB >> 7601263

Effects of BDNF on dopaminergic, serotonergic, and GABAergic neurons in cultures of human fetal ventral mesencephalon.

C Spenger1, C Hyman, L Studer, M Egli, L Evtouchenko, C Jackson, A Dahl-Jørgensen, R M Lindsay, R W Seiler.   

Abstract

The neurotrophin brain-derived neurotrophic factor (BDNF) was tested for its ability to promote the survival and regulation of expression of phenotypic markers of dopaminergic, serotonergic, and GABAergic neurons in free-floating roller tube cultures of human fetal ventral mesencephalon. This culture system contains neurons of the anlage of the substantia nigra as well as that of the rostral raphe nucleus. Dopaminergic neuron number and tyrosine hydroxylase (TH) fiber density was monitored by TH immunocytochemistry. Measurement of dopamine (DA) content, TH enzymatic activity, serotonin (5-HT) content, and glutamic acid decarboxylase (GAD) activity were used as indices of their respective neurotransmitter function. The presence of GABAergic and serotonergic neurons in this culture system was confirmed by GABA and 5-HT immunocytochemistry. In cultures maintained in the presence of BDNF (10 ng/ml), the density of TH-positive cells was increased by 2.5-fold (P F 0.05), and the TH-positive fiber density was increased by 3.5-fold (P F 0.01), relative to control cultures. Similarly, the relative increases in DA content and TH activity were 2.6- and 2.3-fold, respectively, in the BDNF-treated cultures (P F 0.01 and P F 0.01). On a per neuron basis, DA content and TH activity were not markedly changed by BDNF treatment, suggesting that the increases in DA content and TH activity are due to more DA neurons surviving. Relative elevations were also observed in serotonin content (2.0-fold, P F 0.01) and GAD enzymatic activity (1.4-fold, P F 0.01). Future studies will need to determine whether these changes result from the direct action of BDNF on these neurons or through some indirect mechanism. The results demonstrate that BDNF has beneficial effects on cultured human fetal tissue, which may be relevant in optimizing neuronal transplantation techniques, and that multiple systems are simultaneously influenced by BDNF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7601263     DOI: 10.1006/exnr.1995.1007

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  16 in total

1.  Ultrastructural localization of full-length trkB immunoreactivity in rat hippocampus suggests multiple roles in modulating activity-dependent synaptic plasticity.

Authors:  C T Drake; T A Milner; S L Patterson
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

Review 2.  Neurotrophic mechanisms in drug addiction.

Authors:  Carlos A Bolaños; Eric J Nestler
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

3.  Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.

Authors:  L Sklair-Tavron; W X Shi; S B Lane; H W Harris; B S Bunney; E J Nestler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

4.  Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies.

Authors:  Renee F Ren-Patterson; Lauren W Cochran; Andrew Holmes; Klaus-Peter Lesch; Bai Lu; Dennis L Murphy
Journal:  Cell Mol Neurobiol       Date:  2006-09-22       Impact factor: 5.046

5.  Cognitive and neurochemical alterations in hyperhomocysteinemic rat.

Authors:  Lin Gao; Xiao-Ning Zeng; Hong-Ming Guo; Xu-Ming Wu; Hui-Juan Chen; Rong-Ke Di; Ying Wu
Journal:  Neurol Sci       Date:  2011-06-07       Impact factor: 3.307

6.  Physical exercise alleviates ADHD symptoms: regional deficits and development trajectory.

Authors:  Trevor Archer; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-18       Impact factor: 3.911

7.  Effects of brain-derived neurotrophic factor on neuronal structure of dopaminergic neurons in dissociated cultures of human fetal mesencephalon.

Authors:  L Studer; C Spenger; R W Seiler; A Othberg; O Lindvall; P Odin
Journal:  Exp Brain Res       Date:  1996-03       Impact factor: 1.972

8.  Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers.

Authors:  Erik G Jönsson; Peter Saetre; Bodil Edman-Ahlbom; Anna Sillén; Agneta Gunnar; Dimitrios Andreou; Ingrid Agartz; Göran Sedvall; Håkan Hall; Lars Terenius
Journal:  J Neural Transm (Vienna)       Date:  2008-09-10       Impact factor: 3.575

9.  Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal.

Authors:  S Numan; S B Lane-Ladd; L Zhang; K H Lundgren; D S Russell; K B Seroogy; E J Nestler
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 10.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.